CFDB - Cystic Fibrosis DataBase

ongoing trials trial from

A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis - Phase 2|Phase 3 - Not yet recruiting

Study design (if review, criteria of inclusion for studies)

Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment


Cystic Fibrosis - 12 Years and older   (Child, Adult, Older Adult)


Drug: OligoG Dry powder for inhalation

Outcome measures

Forced Expiratory Volume in 1 second (FEV1)|Lung Clearance Index (LCI)|Sputum culture microbiology|Pulmonary Exacerbations

Keywords: OligoG; other anti-bacterial agents; Anti-Bacterial Agents; pharmacological_intervention; Colonization; Respiratory Tract Infections; Respiratory Tract Diseases; Infection; Bacterial Infections; Pseudomonas aeruginosa; Pseudomonas;